Trastuzumab: A drug developed by recombinant DNA technology
The medicine Hertraz contains Trastuzumab as an active ingredient along with inactive ingredients, including α,α-trehalose dihydrate, L-histidine HCl monohydrate, L-histidine, and polysorbate 20. Healthcare providers recommend this drug in treating patients with types of breast cancer and advanced or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma. Trastuzumab multi-dose vials come in 440 mg for intravenous infusion. Trastuzumab is produced through recombinant DNA technology in a Chinese Hamster Ovary cell culture containing the antibiotic gentamicin. Gentamicin is not detectable in the end product. This drug is a sterile, white to pale yellow, preservative-free lyophilized powder.
Hertraz 440 mg injection is available with licensed generic medicine suppliers in India. For further queries, please ring us on 18008891064.